Mammographic Screening of Women Attending a Reference Service Center in Southern Brazil

  • Lopes, Tiara Cristina Romeiro ;
  • Gravena, Angela Andreia Franca ;
  • de Oliveira Demitto, Marcela ;
  • Brischiliari, Sheila Cristina Rocha ;
  • Borghesan, Deise Helena Pelloso ;
  • Agnolo, Catia Millene Dell ;
  • de Barros Carvalho, Maria Dalva ;
  • Pelloso, Sandra Marisa
  • Published : 2016.04.11


Background: To investigate the prevalence of and factors associated with performance of annual mammography by women above 40 years of age. Materials and Methods: This cross-sectional retrospective study was conducted at an oncology reference service in Southern Brazil from October 2013 to October 2014 with 525 women aged 40 years or older. Results: The prevalence of annual mammography was 54.1%; annual mammographic screening was performed for women without private medical insurance, who were under hormone replacement therapy and who had used contraception in the past. An association was found between non-performance of breast clinical and self-examination and non-performance of mammographic screening. Conclusions: Use of mammography for breast cancer screening in the public health care setting proved to be accessible; nevertheless, the proportion of screened women was low, and they exhibited poor adherence to the basic measures of care recommended for breast assessment. Thus, control of breast cancer requires implementing actions targeting the population most vulnerable to non-adherence to screening in addition to continuously monitoring and assessing that population to reduce the prevalence of this disease.


Mammography;screening;breast cancer;early diagnosis;preventive health care;Brazil


  1. Akhtari-Zavare M, Juni MH, Ismail IZ, et al (2015). Health Beliefs and Breast Self-Examination among Undergraduate Female Students in Public Universities in Klang Valley, Malaysia. Asian Pac J Cancer Prev, 16, 4019-23.
  2. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice (US) (2011). ACOG practice bulletin No. 122: breast cancer screening. Obstet Gynecol, 118, 372-82.
  3. Brasil (2004). Ministerio da saude. controle do cancer de mama. documento de consenso. brasilia (DF): ministerio da saude.
  4. Brasil (2011). Ministerio da saude. manual de bases tecnicas da oncologia - sia/sus - sistema de informacoes ambulatoriais. secretaria de atencao a saude/ departamento de regulacao, avaliacao e controle/coordenacao geral de sistemas de informacao.
  5. Brasil (2014)a. Instituto nacional do cancer jose alencar gomes da silva. coordenacao geral de prevencao e vigilancia. estimativa 2014: incidencia de cancer no brasil. rio de janeiro: INCA, Brasil.
  6. Brasil (2014)b. Ministerio da Saude. Departamento de Informatica do SUS (DATASUS). Informacoes de Saude.
  7. Brasil (2014)c. Ministerio da saude. instituto nacional do cancer jose alencar gomes da silva. coordenacao geral de prevencao e vigilancia. divisao de deteccao precoce e apoio a organizacao de rede. ficha tecnica de indicadores relativos as acoes de controle do cancer de mama. rio de janeiro: INCA, Brasil.
  8. Chetlen A, Mack J, Chan T (2015). Breast cancer screening controversies: who, when, why, and how? Clinical imaging, 1-4.
  9. De Moura NAV, Castro VB, De Oliveira Costa MA (2014). Epidemiological profile of women with breast cancer treated in hospital philanthropic reference/Perfil epidemiologico de mulheres com cancer de mama tratadas em hospital filantropico de referencia. Revista de Enfermagem da UFPI, 2, 35-41.
  10. Duffy SW, Chen TH, Smith RA, et al (2013). Real and artificial controversies in breast cancer screening. Breast Cancer Management, 2, 519-528.
  11. El Bcheraoui C, Basulaiman M, Wilson S, et al (2015). Breast Cancer Screening in Saudi Arabia: Free but Almost No Takers. PLoS One, 10, 119051.
  12. Ersin F, Bahar Z (2013). Barriers and facilitating factors perceived in Turkish women's behaviors towards early cervical cancer detection: A qualitative approach. Asian Pac J Cancer Prev, 14, 4977-82.
  13. Euhus D, Di Carlo PA, Khouri NF (2015). Breast Cancer Screening. Surg Clin North Am, 95, 991-1011.
  14. Hassan LM, Mahmoud N, Miller AB, et al (2015). Evaluation of effect of self-examination and physical examination on breast cancer. Breast, 24, 487-90.
  15. Haukka J, Byrnes G, Boniol M, et al (2011). Trends in Breast Cancer Mortality in Sweden before and after Implementation of Mammography Screening. PLoS ONE, 6, 22422.
  16. Heywang-Kobrunner SH, Hacker A, Sedlacek S (2011). Advantages and disadvantages of mammography screening. Breast Care (Basel), 6, 199-207.
  17. Iarc. Agencia Internacional de Pesquisas com Cancer (2012). GLOBOCAN-Cancer Incidence and Mortality Worldwide. Available at:
  18. kalager M, Zelen M, Langmark F, et al (2010). Effect of screening mammography on breast-cancer mortality in Norway. New England Journal of Medicine, 363, 1203-10.
  19. Kettritz U (2010). Screening of breast cancer - an eternal discussion revisited? Breast Care (Basel), 5, 119-20.
  20. Marques CA, Figueiredo EN, Gutierrez MG (2015). Validacao de instrumento para identificar acoes de rastreamento e deteccao de neoplasia de mama. Acta Paulista de Enfermagem, 28, 183-89.
  21. Martins CA, Guimaraes RM, Silva RL, et al (2013). Evolucao da mortalidade por cancer de mama em mulheres jovens: desafios para uma Politica de Atencao Oncologica. Rev Bras Cancerol, 59, 341-49.
  22. Memon ZA, Shaikh AN, Rizwan S, et al (2013). Reasons for patient's delay in diagnosis of breast carcinoma in Pakistan. Asian Pac J Cancer Prev, 14, 7409-14.
  23. Miles A, Cockburn J, Smith RA, et al (2004). A perspective from countries using organized screening programs. Cancer, 101, 1201-13.
  24. Ministerio da Saude (2010). Instituto Nacional de Cancer. SISMAMA - Informacao para o avanco das acoes de controle do cancer de mama no Brasil.
  25. Onega T, Beaber EF, Spraque BL, et al (2014). Breast Cancer Screening in an Era of Personalized Regimens: A Conceptual Model and National Cancer Institute Initiative for Risk-Based and Preference-Based Approaches at a Population Level. Cancer, 120, 2955-64.
  26. Paiva CJK, Cesse EAP (2015). Aspectos relacionados ao atraso no diagnostico e tratamento do cancer de mama em uma unidade hospitalar de pernambuco. Revista Brasileira de Cancerologia, 61, 23-30.
  27. Predna L, Habanova M, Slavikova E, et al (2015). Hormonal contraceptives and hormone replacement therapy as a possible risk factor for breast cancer. Rocz Panstw Zakl Hig, 66, 269-74.
  28. Romeiro-Lopes TC, Gravena AAF, Dell Agnolo CM, et al (2015). Cobertura estimada de mamografia no estado do Parana. Ciencia Saude, 8, 48-53.
  29. Sufian SN, Masroor I, Mirza W, et al (2015). Evaluation of common risk factors related to breast carcinoma in females: a hospital based study in Karachi, Pakistan. Asian Pac J Cancer Prev, 16, 6347-52.
  30. Fakir SE, Najdi A, Khazraji YC, et al (2015). Breast Cancer Screening in Morocco: Performance Indicators During Two Years of an Organized Programme. Asian Pac J Cancer Prev, 16, 6285-8.
  31. Schneider IJ, Giehl MW, Boing AF, et al (2014). Rastreamento mamografico do cancer de mama no Sul do Brasil e fatores associados: estudo de base populacional. Cad. Saude Publica, 30, 1987-97.
  32. Silva FX, Katz L, Souza ASR, et al (2014). Mammography in asymptomatic women aged 40-49 years. Rev Saude Publica [online], 48, 931-39.
  33. Smith RA (2011). International programs for the detection of breast cancer. Salud Publica Mex, 53, 394-404.
  34. Sprague BL, Gangnon RE, Hampton JM, et al (2015). Variation in breast cancer-risk factor associations by method of detection: results from a series of case-control studies. Am J Epidemiol, 181, 956-69.
  35. Tabar L, Dean PB, Chen TH-H, et al (2014). The impact of mammography screening on the diagnosis and management of early phase breast cancer. In: Francescatti D, Silverstein M, eds. Selected Topics in Breast Surgery. Berlin: Springer; 2014.
  36. Tiezzi DG (2010). Cancer de mama: um futuro desafio para o sistema de saude nos paises em desenvolvimento. Rev Bras Ginecol Obstet, 32, 257-59.
  37. US Preventive Services Task Force (2009). Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Int Med, 151, 716-26.
  38. Yilmaz D, Bebis H, Ortabag T (2012). Determining the awareness of and compliance with breast cancer screening among Turkish residential women. Asian Pac J Cancer Prev, 14, 3281-88.

Cited by

  1. Diretrizes para detecção precoce do câncer de mama no Brasil. III - Desafios à implementação vol.34, pp.6, 2018,